Mathilde/NLI4PR huggingface dataset:
Patient case (clinical description): A 33-year-old woman comes to clinic complaining of progressive fatigue, decreased appetite, and 11-lb weight loss in the past 2 months.  She uses levothyroxine because of the previously diagnosed Hashimoto disease. She has no other medical conditions and does not use tobacco, alcohol, or illicit drugs.  Physical examination shows a generalized increase in pigmentation of the skin.  Measurement of serum cortisol before and after administration of exogenous adrenocorticotropic hormone (ACTH) shows no difference in the levels. Stable glucocorticoid replacement therapy starts for her with the diagnosis for primary adrenal insufficiency (Addison disease)

Patient's own account: I went to the clinic because I was really suffering from fatigue and decreased appetite and I also lost 11 pounds over the past two months. I'm just 33 years old so that's not normal, especially for a woman. I take levothyroxine because I have been diagnosed with Hashimoto disease. I don't have any other medical condition, and I don't smoke I don't drink, and I don't do drugs. They also did my physical examination and they saw that I had an increase in pigmentation of my skin. They measured my cortisol level before and after giving me some ACTH hormone, and the results came back with no difference whatsoever. The doctor told me I have Addison disease and put me under glucocorticoid therapy.

Clinical trial: Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease

Eligibility criteria:
Inclusion Criteria:

          1. All patients that are being seen at MD Anderson with diagnosed or suspected endocrine
             disease. Patients will be selected from patients undergoing evaluation and/or
             treatment in the Endocrine Center, either by selection from a participating Endocrine
             physician or by screening from study personnel for patients scheduled to be seen in
             the Endocrine Clinic.

          2. In addition, we intend to contact family members of patients who are enrolled on the
             study, and found to be deceased at follow-up, to request permission to obtain cause of
             death, to determine whether cause of death may be related to endocrine disease.

        Exclusion Criteria:

        N/A
No condition on gender to be admitted to the trial.
No healthy subjects accepted to join the trial.



Eligibility (NLI label): Entailment
Patient case (clinical description): A 9-year-old girl is brought to the office for evaluation of short stature and overweight body habitus. The patient's mother and father are 170 cm and 181 cm tall, respectively.  On physical examination, the patient's height is in the 5th percentile of her age.  Other findings include low-set ears, a high arched palate, a webbed neck, and cubitus valgus.  Chromosomal analysis reveals a 45, XO karyotype.

Patient's own account: I took my 9-year-old daughter to the doctor because my mother-in-law kept saying she seemed small and overweight. My husband and I are 170 cm and 181 cm tall, respectively. The physical health highlighted that she is in the 5th percentile of her age. The doctor said that she has low-set ears, a high-arched palate, a webbed neck, and cubitus valgus. She also did a chromosomal analysis, which revealed a 45, XO karyotype.

Clinical trial: Carbohydrates and Children

Eligibility criteria:
Inclusion Criteria:

          -  Male 9 -13 years of age, or female 9- 10 years of age

          -  Tanner stage 1

          -  Subject was born full term

          -  Subject was born normal weight

          -  Subject passes the Physical Activity Readiness Questionnaire

          -  Body mass index >5th percentile and <95th percentile for age and gender

          -  Subject has voluntarily signed and dated a youth assent document

        Exclusion Criteria:

          -  History of metabolic. endocrine, or hyperactivity disorders

          -  Allergy or intolerance to any ingredient found in the study products

          -  Participation in a concomitant trial of a non-registered drug or that otherwise
             conflicts with this study
No condition on gender to be admitted to the trial.
Accepts Healthy Volunteers
Subject must be at least 9 Years old.
Subject must be at most 13 Years

Eligibility (NLI label): Entailment
Patient case (clinical description): A 43-year-old woman, gravida 3 para 3, comes to the clinic complaining of recently painful menstrual cycles.  The patient's last menstrual period was 2 weeks ago. Urine β-hCG is negative. Menarche was at age 12, and menstrual periods occur every 28 days and lasts for 5 days.  She is sexually active with her husband and does not have pain with intercourse. BMI is 23 kg/m2 and Vital signs are normal.  On physical examination, the uterus is uniformly enlarged and tender. She is candidate for hysterectomy with the diagnosis of adenomyosis.

Patient's own account: I'm 43, and I paid a visit to my doctor because my last few periods were insanely painful. My last periods were 2 weeks ago. I already had three pregnancies that gave me the three lovely children. I did a urine test to check for potential pregnancy, and it came back negative. I started to have my periods at the age of 12, and I have been pretty regular with periods every 28 days for 5 days. I'm sexually active with my husband and I do not have any pain when we have sex. My BMI is 23 and my vitals were normal. The doctor performed a physical exam and found that my uterus was tender and enlarged. She proposed me a hysterectomy and diagnosed me with adenomyosis.

Clinical trial: Clinical and Molecular Study of Endometriosis and Adenomyosis

Eligibility criteria:
Inclusion Criteria:

          -  Women of age between - 18 and 42 years old.

          -  In-service care for one of the pelvic pain and/or infertility, or for a pelvic mass.

          -  Having a radiological diagnosis made by a referral practitioner and/or operated in the
             department

        Exclusion Criteria:

          -  HIV-positive women, HBV and HCV

          -  During pregnancy

          -  Having a cancer diagnosis

          -  Refusing to sign a consent.
Female

Subject must be at least 18 Years old.
Subject must be at most 42 Years

Eligibility (NLI label): Contradiction
Patient case (clinical description): A 40-year-old woman comes to the clinic complaining of gritty sensation in her eyes. She also has difficulty swallowing dry foods with no pain or heartburn.  The patient is a schoolteacher and must drink water frequently during lectures due to her mouth dryness.  She also reports occasional joint pain.  Medical history is not significant other than the confirmed Sjogren disease with no other rheumatologic disease.  She is sexually active with her husband and has 2 children both delivered by natural vaginal delivery. She has no history of any kind of surgery. Physical examination shows conjunctival erythema and cracking of the lips. The remainder of the examination and history is normal. Her lab result shows elevated ESR (50 mm/h)

Patient's own account: I went to the clinic because I had a terrible gritty sensation in my eyes. It was also hard to swallow dry food, but it didn't burn, and there was no pain. I'm a 40-year-old female school teacher and I should drink water for the lectures because otherwise, my mouth gets really dry. I also have joint pain from time to time. I have been diagnosed with Sjogren disease but no other rheumatologic disease. I have a husband, we're sexually active, and I also have two lovely children that I delivered both naturally. I never undergone any surgery. Physical examination when I came to the clinic, and it showed cracking on my lips and a pink eye. The rest was fine. I also did some lab tests, and they came back with high ESR.

Clinical trial: Laser Therapy to Treat the Dry Mouth of Sjogren's Syndrome

Eligibility criteria:
Inclusion Criteria:

          -  Patients with primary Sjogren Syndrome according criteria american european 2002.

          -  Salivary flux non stimulated < 0,1 ml/min.

        Exclusion Criteria:

          -  hepatitis B and/or C

          -  radiotherapy in the glandular area (previous)

          -  other connective diseases

          -  thyroidopathy non compensated

          -  GVHD graft-versus-host disease

          -  HIV

          -  Sarcoidosis
No condition on gender to be admitted to the trial.
No healthy subjects accepted to join the trial.
Subject must be at least 18 Years old.
Subject must be at most 80 Years

Eligibility (NLI label): Entailment
Patient case (clinical description): A 2-year-old boy is brought to the office by his parents due to a rash that started 1 week ago.  A similar red, itchy rash on the cheeks, trunk, and arms has occurred intermittently since infancy.  The patient has had a few upper respiratory infections but no major illnesses.  Vaccinations are up to date, and he takes no medications. He is on a balanced diet, and he is healthy in appearance.  Vital signs and milestone examination are within normal limits.  Similar findings are observed on the cheeks and proximal upper extremities.  The diaper area is clear, and no mucosal lesions are present.

Patient's own account: I just brought my two-year-old son to the doctor's office because he had a rash for like one week. His rash was on the cheeks, the trunk, and his arms. He already had this before, and it keeps coming back from time to time to time. In the past, he had some respiratory infections but he has never been this sick. His vaccinations are up to date, and he doesn't take any medication. He's healthy with a nice diet. The doctor told me his vitals and milestone examinations were normal. The doctor also said there was a rash around the cheek and the upper part of his arms. The diaper area is okay, and there are no lesions.

Clinical trial: Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic Dermatitis

Eligibility criteria:
Inclusion Criteria:

          -  Mild to moderate facial atopic dermatitis

          -  Patients intolerant of, or dependent on, topical corticosteroids

        Exclusion Criteria:

          -  Concurrent skin diseases (infections)

          -  Immunocompromised

          -  Recently received phototherapy or systemic therapy
No condition on gender to be admitted to the trial.

Subject must be at least 2 Years old.
Subject must be at most 11 Years

Eligibility (NLI label): Entailment